Related references
Note: Only part of the references are listed.Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation
Julian Hofmann et al.
CHEMISTRY-A EUROPEAN JOURNAL (2021)
Study of reactions of Nε-(carboxymethyl) lysine with o-benzoquinones by cyclic voltammetry
Yuting Li et al.
FOOD CHEMISTRY (2020)
Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms
Katiuscia Pagano et al.
FRONTIERS IN NEUROSCIENCE (2020)
Lights and shadows of electrophile signaling: focus on the Nrf2-Keap1 pathway
Filippo Basagni et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach
Elena Simoni et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer's Disease
Elena Simoni et al.
CHEMMEDCHEM (2016)
Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery
Xian-Le Bu et al.
MOLECULAR NEUROBIOLOGY (2016)
Amylin Amyloid Inhibition by Flavonoid Baicalein: Key Roles of Its Vicinal Dihydroxyl Groups of the Catechol Moiety
Paul Velander et al.
BIOCHEMISTRY (2016)
Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic-Inhibitor and Histidine-Inhibitor Interactions
Ling-Hsien Tu et al.
BIOCHEMISTRY (2015)
Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs
Takumi Satoh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues
Mizuho Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1-42 Dimer
Tong Zhang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
Fernando L. Palhano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry
Jessica Fiori et al.
ELECTROPHORESIS (2012)
Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach
Manuela Bartolini et al.
ANALYTICAL BIOCHEMISTRY (2011)
Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species
Asad Jan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention
Sarah C. Forester et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor
Roni Scherzer-Attali et al.
PLOS ONE (2010)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease
Summer L. Bernstein et al.
NATURE CHEMISTRY (2009)
9,10-Anthraquinone hinders β-aggregation: How does a small molecule interfere with Aβ-peptide amyloid fibrillation?
Marino Convertino et al.
PROTEIN SCIENCE (2009)
Insight into the kinetic of amyloid β(1-42) peptide self-aggregation:: Elucidation of inhibitors' mechanism of action
Manuela Bartolini et al.
CHEMBIOCHEM (2007)
Preformed β-amyloid fibrils are destabilized by coenzyme Q10 in vitro
K Ono et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Methionine 35 oxidation reduces fibril assembly of the amyloid Aβ-(1-42) peptide of Alzheimer's disease
LM Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
